We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+13.28%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$168M
AUM Growth
-$6.63M
Cap. Flow
-$14M
Cap. Flow %
-8.3%
Top 10 Hldgs %
40.66%
Holding
139
New
26
Increased
28
Reduced
31
Closed
34

Sector Composition

Rank Sector Weight
1 Healthcare 46.64%
2 Technology 19.92%
3 Financials 17.76%
4 Consumer Discretionary 3.48%
5 Communication Services 2.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DELL icon
1
Dell
DELL
$239B
$14.3M 8.49%
355,444
MA icon
2
Mastercard
MA
$498B
$12.9M 7.68%
37,194
+170
+0.5% +$56K
V icon
3
Visa
V
$677B
$8.83M 5.24%
42,515
-742
-2% -$150K
FISV
4
Fiserv Inc
FISV
$29.7B
$8.68M 5.16%
85,926
-408
-0.5% -$40.6K
MSDAU
5
DELISTED
MSD Acquisition Corp. Unit
MSDAU
$5.05M 3%
500,000
AXSM icon
6
Axsome Therapeutics
AXSM
$11.7B
$4.25M 2.52%
55,124
+38,238
+226% +$2.29M
CPNG icon
7
Coupang
CPNG
$27.2B
$3.77M 2.24%
256,264
PYPL icon
8
PayPal
PYPL
$49.9B
$3.75M 2.22%
52,618
-684
-1% -$54.7K
IWD icon
9
iShares Russell 1000 Value ETF
IWD
$81.4B
$3.61M 2.14%
23,825
FHN icon
10
First Horizon
FHN
$12.2B
$3.32M 1.97%
135,400
ATVI
11
DELISTED
Activision Blizzard
ATVI
$3.06M 1.82%
40,000
TGNA
12
DELISTED
TEGNA Inc
TGNA
$3.05M 1.81%
144,000
ACRS icon
13
Aclaris Therapeutics
ACRS
$715M
$2.95M 1.75%
187,619
-30,199
-14% -$486K
VRDN icon
14
Viridian Therapeutics
VRDN
$2.2B
$2.92M 1.73%
99,982
-2,390
-2% -$55.1K
VMW
15
DELISTED
VMware, Inc
VMW
$2.9M 1.72%
23,600
SJI
16
DELISTED
South Jersey Industries, Inc.
SJI
$2.82M 1.68%
+79,500
New +$2.75M
BCYC
17
Bicycle Therapeutics
BCYC
$269M
$2.74M 1.62%
92,434
-44,325
-32% -$1.19M
RLAY icon
18
Relay Therapeutics
RLAY
$4B
$2.64M 1.57%
176,521
+9,138
+5% +$175K
BKI
19
DELISTED
Black Knight, Inc. Common Stock
BKI
$2.61M 1.55%
42,200
TVTX icon
20
Travere Therapeutics
TVTX
$5.17B
$2.56M 1.52%
121,834
+11,136
+10% +$236K
CBAY
21
DELISTED
Cymabay Therapeutics
CBAY
$2.48M 1.47%
395,332
RPTX
22
DELISTED
Repare Therapeutics
RPTX
$2.43M 1.44%
164,890
-139,291
-46% -$2.08M
COGT icon
23
Cogent Biosciences
COGT
$6.76B
$2.13M 1.26%
183,984
+65,049
+55% +$806K
RXDX
24
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$2.12M 1.26%
19,276
+11,445
+146% +$742K
ISEE
25
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$2.1M 1.25%
98,094
+64,034
+188% +$1.37M

Similar funds

HighVista Strategies's Q4 2022 Portfolio in Review

As of Q4 2022, HighVista Strategies held 139 positions worth $168M, down 3.8% from $175M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

HighVista Strategies withdrew a net $14M in Q4 2022, closing 34 positions and reducing 31 holdings. Its most notable exit was Change Healthcare Inc. Common Stock, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 46% a quarter earlier, followed by Technology and Financials.

Against the trend, HighVista Strategies opened a new position in South Jersey Industries, Inc. worth $2.82M.

  • HighVista Strategies's largest Q4 2022 buy was South Jersey Industries, Inc.: 79,500 shares worth $2.82M.
  • HighVista Strategies added most to Axsome Therapeutics in Q4 2022, an estimated $2.29M increase.
  • HighVista Strategies's biggest Q4 2022 reduction was Repare Therapeutics, cutting an estimated $2.08M.
  • HighVista Strategies fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $4.46M.
  • HighVista Strategies's ten largest holdings make up 41% of its $168M portfolio in Q4 2022.
  • HighVista Strategies opened 26 new positions and closed 34 in Q4 2022.
  • HighVista Strategies's portfolio value fell 3.8% quarter-over-quarter to $168M.

Based on HighVista Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.